safeguards for clinical research with adults who are unable to consent. Thr
ee other major U.S. groups have also proposed additional safeguards for thi
s population, and existing Canadian and European guidelines already include
such safeguards. While these six guidelines agree on some safeguards, they
disagree on others. To allow Important research to proceed while protectin
g adults who are unable to consent, it will be crucial to resolve these dif
ferences. This paper uses a side-by-side comparison of these six guidelines
to highlight their major points of consensus, analyze their significant di
fferences, and distill six core safeguards.